|
2024
|
Invention
|
Sulfonamide derivatives as cyclin-dependent kinase 2 inhibitors. The present disclosure provides ... |
|
|
Invention
|
Alkylidene derivatives as kras inhibitors.
The present disclosure provides certain alkylidenyl d... |
|
|
Invention
|
Bifunctional compounds for degrading kras-12d via ubiquitin proteasome pathway. The present discl... |
|
2023
|
Invention
|
Bifunctional compounds containing 2,5-substituted pyrimidine derivatives for degrading cyclin-dep... |
|
|
G/S
|
Anti-cancer preparations; pharmaceutical preparations for the treatment of cancer |
|
|
G/S
|
Anti-cancer preparations; Pharmaceutical preparations for the treatment of cancer. |
|
|
G/S
|
Anti-cancer preparations; Pharmaceutical preparations for the treatment of cancer |
|
|
Invention
|
Bifunctional compounds for degrading kras g12d via ubiquitin proteasome pathway. The present disc... |
|
|
Invention
|
Alkylidene carbamate as kras inhibitors. Provided herein are certain alkylidenyl carbamate compou... |
|
|
Invention
|
Tetrahydro-1h-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors.
... |
|
|
Invention
|
Bifunctional compounds containing substituted pyrimidine derivatives for degrading cyclin-depende... |
|
|
Invention
|
Bifunctional compounds containing pyrido[2,3-djpyrimidin-7(8h)-one derivatives for degrading cycl... |
|
|
Invention
|
Bifunctional compounds containing pyrimidine derivatives for degrading cyclin-dependent kinase 2 ... |
|
|
Invention
|
Sulfamide derivatives as cyclin-dependent kinase 2 inhibitors. The present disclosure provides ce... |
|
|
Invention
|
Tetracyclic derivatives as kras inhibitors. Provided are certain tetracyclic derivatives that inh... |
|
|
Invention
|
Tricyclic derivatives as kras inhibitors. The present disclosure provides certain tetracyclic der... |
|
|
Invention
|
Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors. The present disclosure provides ... |
|
|
Invention
|
Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors |
|
|
Invention
|
Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors.
The present disclosure provides... |
|
|
Invention
|
Process of preparing 3-fluoro-5(((1r,2ar)-3,3,4,4-tetrafluoro-1,2a-dihydroxy-2,2a,3,4-tetrahydro-... |
|
|
Invention
|
Tetracyclic derivatives as kras inhibitors. The present disclosure provides certain tetracyclic d... |
|
|
Invention
|
Bifunctional compounds for degrading kras g12d via ubiquitin proteasome pathway. Disclosed herein... |
|
2022
|
Invention
|
Fused tricyclic ring derivatives as src homology-2 phosphate inhibitors. The present disclosure p... |
|
|
Invention
|
Processes of making 3-fluoro-5-(((1r,2s,2as)-1,2,3,3,4,4-hexafluoro-2a-hydroxy-2,2a,3,4-tetrahydr... |
|
|
Invention
|
Hypoxia inducible factor-2(alpha) inhibitors for the treatment of bladder cancer.
The present di... |
|
|
Invention
|
Hypoxia inducible factor-2(alpha) inhibitors for the treatment of bladder cancer. The present dis... |
|
|
Invention
|
Processes of making 3-fluoro-5-(((1s,2ar)-1,3,3,4,4-pentafluoro-2a- hydroxy-2,2a,3,4-tetrahydro-1... |
|
|
Invention
|
Processes of making 3-fluoro-5-(((1s,2ar)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1h... |
|
|
Invention
|
Bifunctional compounds for degrading kras g12d via ubiquitin proteasome pathway. Providing certai... |
|
|
Invention
|
Alkylidene carbamate as kras inhibitors. Provided are certain alkylidenyl carbamate compounds tha... |
|
|
G/S
|
Anti-cancer preparations; pharmaceutical preparations for the treatment of cancer. |
|
|
Invention
|
Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases.
The pre... |
|
|
Invention
|
Alkylidene derivatives as kras inhibitors. The present disclosure provides certain alkylidenyl de... |
|
|
Invention
|
Quinazoline amine derivatives as kras inhibitors.
The present disclosure provides certain quinaz... |
|
|
Invention
|
Quinazoline nitrile derivatives as kras inhibitors. The present disclosure provides certain quina... |
|
|
Invention
|
Quinazoline amine derivatives as kras inhibitors. The present disclosure provides certain quinazo... |
|
|
Invention
|
Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases. The pres... |
|
|
G/S
|
Anti-cancer preparations; pharmaceutical preparations for the treatment of cancer |
|
2021
|
Invention
|
Compounds for degrading cyclin-dependent kinase 2 via ubiquitin proteosome pathway.
The present ... |
|
|
Invention
|
Compounds for degrading cyclin-dependent kinase 2 via ubiquitin proteosome pathway. The present d... |
|
|
Invention
|
Processes of making 3-fluoro-5- ( ( (1r, 2s, 2as) -1, 2, 3, 3, 4, 4-hexafluoro-2a-hydroxy-2, 2a, ... |
|
|
Invention
|
Processes of making 3-fluoro-5- ( ( (1s, 2ar) -1, 3, 3, 4, 4-pentafluoro-2a-hydroxy-2, 2a, 3, 4-t... |
|
|
Invention
|
Exocyclic amino quinazoline derivatives as kras inhibitors. The present disclosure provides certa... |
|
2020
|
Invention
|
Tricyclic derivatives as hypoxia inducible factor-2(alpha) inhibitors.
The present disclosure pr... |
